Cancer Medicine - Wiley Online Library
專家告訴你腫瘤學SCI 期刊怎麼投？ - 壹讀
ATOM: Atovaquone as Tumour HypOxia Modifier — Department of Oncology
Home - Translational Cancer Research
Clinical Cancer Research (@CCR_AACR) / Twitter
Home - Translational Cancer Research
1 Manuscript Type: Research Article Category: Clinical Therapy Title ...
Tips for Success As an Academic Clinical Investigator | Journal of Clinical Oncology
PDF) Efficacy of Chemotherapy in BRCA1/2 Mutation Carrier Ovarian Cancer in the Setting of PARP Inhibitor Resistance: A Multi-Institutional Study
Clinical Cancer Research: Immunotherapy of ipilimumab and nivolumab - NeuroEndocrine Cancer Australia
Journal of Experimental & Clinical Cancer Research | Home page
PDF) Identification of a novel, EBV-based antibody risk stratification signature for early detection of nasopharyngeal carcinoma in Taiwan | Jaap Middeldorp - Academia.edu
Clinical Cancer Research (@CCR_AACR) / Twitter
Cancer Research – Page 4 – Drug Discovery World (DDW)
Buy Translational Pancreatic Cancer Research: From Understanding of Mechanisms to Novel Clinical Trials (Molecular and Translational Medicine) Book Online at Low Prices in India | Translational Pancreatic Cancer Research: From Understanding of
Circulating Bmi-1 mRNA as a possible prognostic factor for advanced breast cancer patients – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open
Journal of Experimental & Clinical Cancer Research | Home page
The anti-HER3 monoclonal antibody seribantumab effectively inhibits growth of patient-derived and isogenic cell line and xenograft models with oncogenic NRG1 fusions - Elevation Oncology
Clinical Cancer Research | Publons
International Journal of Cancer - Wiley Online Library
PDF) A Three-Gene Expression Signature Model for Risk Stratification of Patients with Neuroblastoma | Garrett Brodeur - Academia.edu
Journal of Cancer Research and Clinical Oncology | Home
Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial - The Lancet Oncology
